Diabetic nephropathy is characterized by thickening of the glomerular basement membrane and expansion of the mesangial matrix. The glomerular basement membrane is assembled from at least five genetically distinct collagen IV chains. In patients with diabetic nephropathy, differential distribution of these components has been demonstrated. In order to clarify the relationship between progression of diabetic nephropathy and altered type IV collagen assembly in the renal cortex, we examined steady state mRNA levels encoding collagen IV subchains in the kidney cortices of spontaneously diabetic KKAy mice and nondiabetic C57black mice as controls. They were sacrificed at 4, 8, 16, and 24 weeks of age. Northern and dot blot analyses were performed using 32P-labeled mouse probes for classical α1(IV) and α2(IV) and for α3(IV), α4(IV), and α5(IV) minor chains. The mRNA levels for all collagen IV chains peaked at 4 weeks of age and declined rapidly thereafter in the nondiabetic mice. At all times, α1(IV) and α2(IV) mRNA expressions were abundant and almost unchanged in KKAy mice. In contrast, mRNA levels for α3(IV), α4(IV), and α5(IV) progressively changed with age. It appears that the expression of minor collagen IV chains is dissociated from the α1(IV) and α2(IV) chains in diabetic nephropathy. Moreover, an unbalanced increase in the production may affect collagen IV assembly and contribute to basement membrane thickening in diabetic nephropathy of KKAy mice.

Keywords:
Type IV collagen, Gene expression, Diabetic nephropathy, KKAy mouse
1.
Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993;22:736–744.
2.
Gilbert RE, Cox A, Dziadek M, Cooper ME, Jerums G: Extracellular matrix and its interactions in the diabetic kidney: A molecular biological approach. J Diabetes Complications 1995;9:252–254.
3.
Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143–1155.
4.
Breyer JA: Diabetic nephropathy in insulin-dependent patients. Am J Kidney Dis 1992;20:533–547.
5.
Hudson BG, Reeders ST, Tryggvason K: Type IV collagen: Structure, gene organization, and role in human diseases. J Biol Chem 1993;268:26033–26036.
6.
Kleppel MM, Santi PA, Cameron JD, Wieslander J, Michael AF: Human tissue distribution of novel basement membrane collagen. Am J Pathol 1989;134:813–825.
7.
Butokowski RJ, Wieslander J, Kleppel M, Michael AF, Fish AJ: Basement membrane collagen in the kidney: Regional localization of novel chains related to collagen IV. Kidney Int 1989;35:1195–1202.
8.
Butkowski RJ, Langeveld JPM, Wieslander J, Hamilton J, Hudson BG: Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem 1987;262:7874–7877.
9.
Saus J, Wieslander J, Langeveld JPM, Quinones S, Hudson BG: Identification of the Goodpasture antigen as the α3(IV) chain of collagen IV. J Biol Chem 1988;263:13374–13380.
10.
Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990;248:1224–1227.
11.
Hostikka SL, Eddy RL, Byers MG, Höyhtyä M, Shows TB, Tryggvason K: Identification of a distinct type IV collagen α chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci USA 1990;87:1606–1610.
12.
Ding J, Kashtan E, Fan WW, Kleppel MM, Sun MJ, Kalluri R, Neilson EG, Michael AF: A monoclonal antibody marker for Alport antigen as the α5 chain of type IV collagen. Kidney Int 1994;46:1504–1506.
13.
Zhou J, Mochizuki T, Smeets H, Antignac C, Laurilla P, de Paepe A, Tryggvason K, Reeders ST: Delection of the paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors. Science 1993;261:1167–1169.
14.
Kleppel MM, Michael AF: Expression of novel basement membrane components in the developing human kidney and eye. Am J Anat 1990;187:165–174.
15.
Nakanishi K, Yoshikawa N, Iijima K, Kitagawa K, Nakamura H, Ito H, Yoshioka K, Kagawa M, Sado Y: Immunohistochemical study of α1–5 chains of type IV collagen in hereditary nephritis. Kidney Int 1994;46:1413–1421.
16.
Kalluri R, Shield CH III, Todd P, Hudson BG, Neilson EG: Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 1997;99:2470–2478.
17.
Kim Y, Kleppel MM, Butkowski R, Mauer M, Wieslander J, Michael AF: Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 1991;138:413–420.
18.
Yagame M, Kim Y, Zhu D, Suzuki D, Eguchi K, Nomoto Y, Sakai H, Groppoli T, Steffes MW, Mauer SM: Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995;70:42–48.
19.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 1987;162:156–159.
20.
Enders GC, Kahsai TZ, Lian G, Funabiki K, Killen PD, Hudson BG: Developmental changes in semioniferous tubule extracellular matrix components of the mouse testis: α3(IV) Collagen chain expressed at the initiation of spermatogenesis. Biol Reprod 1995;53:1489–1499.
21.
Falk RJ, Scheiman JI, Mauer M, Michael AF: Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 1983;32(suppl 2):34–39.
22.
Abrass CK, Peterson CV, Raugi GJ: Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats. Diabetes 1988;37:1695–1702.
23.
Langeveld JP, Wieslander J, Timoneda J, McKinney P, Butkowski RJ, Wisdom BJ, Hudson BG: Structural heterogeneity of the noncollagenous domain of basement membrane collagen. J Biol Chem 1988;263:10481–10488.
24.
Ledbetter S, Copeland J, Noonan D, Vogeli G, Hassell JR: Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 1990;39:196–203.
25.
Ihm C-G, Lee GSL, Nast CC, Artishevsky A, Guillemo R, Levin PS, Glassock RJ, Adler SG: Early increased renal procollagen α1(IV) mRNA levels in streptozotocin induced diabetes. Kidney int 1992;41:768–777.
26.
Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 1992;41:1520–1527.
27.
Desjardins M, Gros F, Wieslander J, Gubler MC, Bendayan M: Immunogold studies of monomeric elements from the globular domain (NC1) of type IV collagen in renal basement membranes during experimental diabetes in the rat. Diabetologia 1990;33:196–203.
28.
Zhu D, Kim Y, Steffes MW, Groppoli ST, Butkowski RJ, Mauer SM: Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry. Kidney Int 1994;45:425–433.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.